Brief: Aurinia Submits IND Application to US FDA for AUR 200
20/12/2023 11:09
Dec 20 (Reuters) - Aurinia Pharmaceuticals Inc AUPH.O :
* AURINIA SUBMITS IND APPLICATION TO US FOOD & DRUG
ADMINISTRATION
FOR AUR 200
* AURINIA PHARMACEUTICALS INC: PLANS TO INITIATE A PHASE 1
STUDY
IN FIRST HALF OF 2024
Source text for Eikon: ID:nBw8c9S3Ba
Further company coverage: AUPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death